Toronto Immune and Digestive Health Institute Inc. (TIDHI)

North York, Ontario M6A3B4

2 studies enrolling now · 2 studies all time

What they study most

Crohn's Disease, Ulcerative Colitis

Studies at this site

• A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease — Recruiting now
• A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC) — Recruiting now